The Nuclear Magnetic Resonance Spectroscopy Laboratory opens the door to an ambitious research program aimed at the discovery of new therapeutic molecules.
In the Nuclear Magnetic Resonance Spectroscopy Laboratory, researchers will be able to explore the structure and role of atomic-scale molecular movements of families of proteins and enzymes involved in a number of diseases, such as amyotrophic lateral sclerosis (ALS), diabetes, asthma, HIV, immunological diseases, and cancer.
This research capability has the potential to revolutionize drug development practices and give new impetus to the pharmaceutical industry in Quebec and across Canada. It will also provide a unique training environment for highly skilled biotechnology personnel.
Researchers at the Nuclear Magnetic Resonance Spectroscopy Laboratory will have access to a 600 megahertz NMR spectrometer with high throughput screening capabilities to characterize biomolecular interactions between proteins and their ligands. The knowledge gained will be crucial to fragment-based drug design (FBDD), a new pharmaceutical approach aimed at developing better targeted, more effective drugs that cause fewer side effects.
The Nuclear Magnetic Resonance Spectroscopy Laboratory is available to INRS research teams for their projects. Our resources and expertise can also be used for external collaborations and research and development contracts.
Contact us to learn more about the services available.
The Nuclear Magnetic Resonance Spectroscopy Laboratory is funded in part by the Canada Foundation for Innovation (CFI) John R. Evans Leaders Fund and the government of Quebec.
Nuclear Magnetic Resonance Spectroscopy Laboratory
Institut national de la recherche scientifique
531 blvd. des Prairies
Laval, Quebec H7V 1B7